UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
February 13, 2008
---------------------------
Date of Report (Date of earliest event reported)
ASSURED PHARMACY, INC.
-----------------------------------------------
(Exact name of registrant as specified in its charter)
| Nevada | 000-33165 |
98-0233878 |
||
| ------------ | ------------- | -------------- |
||
| (State or other jurisdiction | (Commission |
(IRS Employer |
||
| of incorporation) | File Number) |
Identification No.) |
17935 Sky Park Circle, Suite F, Irvine, CA, 85016
---------------------------------------------------------------
(Address of principal executive offices)
(949) 222-9971
---------------------
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 8.01 Other Events
On February 13, 2008, the Registrant issued a press release announcing that it has consolidated the operation of its pharmacy located at 3822 S.E. Powell Blvd. in Portland, Oregon, which was opened under previous management, into the Registrant’s 10196 SW Park Way pharmacy, also in Portland. The consolidation will allow the Registrant to further leverage its existing infrastructure and is expected to result in a reduction of costs. A copy of the press release is attached hereto as exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
| a) |
Not applicable. |
|
| b) |
Not applicable. |
|
| c) |
Exhibits |
|
|
99.1. Press Release, dated February 13, 2008 |
||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: February 15, 2008 | |||
| ASSURED PHARMACY, INC. | |||
| By: | /s/ Robert DelVecchio | ||
| Name: | Robert DelVecchio | ||
| Title: | Chief Executive Officer | ||